Eli Lilly stock rose Monday after Zepbound received Food and Drug Administration (FDA) approval as a treatment for obstructive sleep apnea among adults with obesity.

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular ...

That includes continuous glucose monitoring systems developed by Lilly's partner Dexcom as well as other manufacturers, as well as wearable devices from ... planners and medical affairs ...

On Friday, Eli Lilly (LLY) reported that the ... not on a positive airway pressure (PAP) device that helps them when sleeping. ResMed Chief Medical Officer Carlos Nunez said that positive results ...

Medical devices stocks are in a strong position “and must be bought,” according to Rich Ross, head of Technical Analysis at Evercore ISI, in a note. The iShares U.S. Medical Device ETF (NYSEARCA:IHI) ...

Eli Lilly has expanded a collaboration with ... against rivals such as Apple and FitBit whose wearable devices have an increasing medical focus with tech like ECG readers. ActiGraph provides ...

Some of these companies also make vaccines, animal health products, medical devices and consumer-related healthcare products. These players invest millions of dollars in their product pipelines ...